Search

Your search keyword '"Weiss, Tobias"' showing total 919 results

Search Constraints

Start Over You searched for: Author "Weiss, Tobias" Remove constraint Author: "Weiss, Tobias"
919 results on '"Weiss, Tobias"'

Search Results

1. High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity

2. A prognostic neural epigenetic signature in high-grade glioma

3. Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

6. Customer Decision-Making Processes Revisited: Insights from an Eye Tracking and ECG Study Using a Hidden Markov Model

8. Explainable AI for tailored electricity consumption feedback -- an experimental evaluation of visualizations

9. The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers

10. Federated Learning Enables Big Data for Rare Cancer Boundary Detection

12. Glioma progression is shaped by genetic evolution and microenvironment interactions

16. Author Correction: Federated learning enables big data for rare cancer boundary detection

18. A T-cell antigen atlas for meningioma: novel options for immunotherapy

19. From Simulated to Real Environments: Q-Learning for MAZE-Navigation of a TurtleBot

20. Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma

27. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10

30. Auf der Jagd nach der Sonne

32. Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling

33. Table S1 from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

34. Supp Figures from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

35. Supplemental Figures Legends from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

36. Data from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

37. Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

41. Tripokin: A multi‐specific immunocytokine for cancer immunotherapy.

45. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

46. The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

49. Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo.

50. A clinically compatible drug‐screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis

Catalog

Books, media, physical & digital resources